The 78 rating InvestorsObserver gives to Neurosense Therapeutics Ltd (NRSN) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 91 percent of stocks in the Biotechnology industry, NRSN’s 78 overall rating means the stock scores better than 78 percent of all stocks.
NRSN has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on NRSN!
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Neurosense Therapeutics Ltd Stock Today?
Neurosense Therapeutics Ltd (NRSN) stock has fallen -2.97% while the S&P 500 has gained 0.58% as of 10:07 AM on Friday, Mar 8. NRSN has fallen -$0.06 from the previous closing price of $2.01 on volume of 67,236 shares. Over the past year the S&P 500 has risen 32.38% while NRSN has gained 12.07%. NRSN lost -$0.86 per share the over the last 12 months.
Click Here to get the full Stock Report for Neurosense Therapeutics Ltd stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
